Our Pricing

How to Begin Mounjaro Treatment Safely in the UK

Understanding how to start Mounjaro safely in the UK requires proper clinical guidance and a structured titration schedule. At Cured Pharmacy, our UK-registered prescribers assess your suitability and provide personalised dosing plans to minimise side effects whilst optimising weight loss outcomes. Mounjaro (tirzepatide) is available from £135.00 following a free online consultation with our clinical team.

Understanding Mounjaro's Mechanism Before You Start

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation and glucose metabolism.

In the SURPASS-3 clinical trial, participants achieved an average body weight reduction of 22.5% over 72 weeks on the 15mg maintenance dose — significantly greater than comparator treatments [1]. This dual mechanism explains why many patients experience more pronounced appetite suppression and earlier satiety signals compared to single-agonist alternatives.

Before beginning treatment, your UK prescriber will evaluate your baseline BMI, medical history, and any contraindications. Mounjaro is typically prescribed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as hypertension or type 2 diabetes, subject to clinical assessment [2].

The Mounjaro Starting Dose and Titration Schedule

All patients begin Mounjaro treatment with the 2.5mg dose, administered once weekly via subcutaneous injection [3]. This initial dose is not intended to produce significant weight loss — rather, it allows your body to gradually adapt to the medication and minimises the risk of gastrointestinal side effects such as nausea and vomiting.

After four weeks on 2.5mg, your prescriber will typically escalate your dose to 5mg weekly, provided you tolerate the initial dose well. The standard UK titration schedule continues with monthly increases: 2.5mg for four weeks, then 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as the maximum maintenance dose [3]. Each increment occurs at four-week intervals, allowing sufficient time for your body to adjust.

Some patients achieve their weight loss goals on lower maintenance doses such as 7.5mg or 10mg and may not require further escalation. Your UK prescriber will review your progress at each stage and determine the optimal dose based on your response, tolerability, and clinical objectives. Never adjust your dose independently — always consult your prescriber before making any changes to your treatment plan.

What to Expect During Dose Escalation

Gastrointestinal symptoms are most common during the first few weeks after each dose increase, typically subsiding as your body adapts [4]. Most patients find these effects manageable with dietary adjustments such as smaller portion sizes, avoiding high-fat meals, and eating slowly. Staying well-hydrated and avoiding alcohol during the initial titration phase can also reduce discomfort.

Weight loss typically accelerates as you reach higher maintenance doses. In clinical trials, the most significant reductions occurred between weeks 20 and 52, with continued gradual loss thereafter [1]. Patience during the early titration phase is essential — the starting doses are designed for tolerability, not immediate dramatic results.

How to Administer Your First Mounjaro Injection

Mounjaro is supplied in a pre-filled KwikPen device designed for ease of use, requiring no manual needle attachment or dose dialling. Each pen contains four doses at a fixed strength, and you'll receive a new pen each month as you progress through the titration schedule.

To administer your injection, select an injection site on your abdomen, thigh, or upper arm. Rotate sites each week to prevent lipohypertrophy (localised fat accumulation under the skin). Clean the area with an alcohol wipe, remove the pen cap, press the pen firmly against your skin, and hold the injection button until you hear a second click — typically about 10 seconds [3]. The KwikPen automatically delivers the correct dose.

Store unused pens in the refrigerator between 2°C and 8°C, but never freeze them. Once you've started using a pen, you can keep it at room temperature (up to 30°C) for up to 21 days. Always check the medication is clear and colourless before injecting — if it appears cloudy or discoloured, do not use it and contact your pharmacist.

Managing Injection Site Reactions

Mild redness, swelling, or itching at the injection site affects approximately 2-3% of patients and usually resolves within a few days [4]. Applying a cool compress and avoiding tight clothing over the area can provide relief. If you develop persistent pain, significant swelling, or signs of infection such as warmth or pus, contact your prescriber immediately.

Bruising is common and typically harmless. To minimise bruising, avoid injecting into areas with visible blood vessels, and don't rub the site after injection. If you're taking anticoagulants or antiplatelet medications, inform your prescriber during your consultation as this may increase bruising risk.

Common Side Effects When Starting Mounjaro

Nausea is the most frequently reported side effect, affecting up to 20% of patients during the initial weeks of treatment [4]. This typically peaks within the first few days after each dose increase and diminishes as your body adapts. Eating smaller, more frequent meals and avoiding rich or spicy foods can significantly reduce nausea intensity.

Other common gastrointestinal effects include diarrhoea, constipation, abdominal discomfort, and reduced appetite. In clinical trials, these symptoms were generally mild to moderate and rarely led to treatment discontinuation [1]. Constipation can be managed with increased fibre intake and hydration, whilst diarrhoea usually resolves without intervention within a few days.

Serious side effects are rare but require immediate medical attention. These include severe persistent abdominal pain (which may indicate pancreatitis), vision changes, signs of thyroid tumours such as a lump in the neck, or symptoms of gallbladder disease including jaundice or severe upper abdominal pain [3]. If you experience any of these symptoms, stop your medication and seek urgent medical advice.

Dietary and Lifestyle Adjustments for Optimal Results

Mounjaro works most effectively when combined with a reduced-calorie diet and increased physical activity. In the SURMOUNT-1 trial, participants followed a structured lifestyle intervention programme alongside medication, contributing to the significant weight loss outcomes observed [2]. Your prescriber may recommend a calorie deficit of 500-750 kcal per day, tailored to your baseline requirements.

Focus on protein-rich foods to preserve lean muscle mass during weight loss. Aim for at least 1.2-1.6g of protein per kilogram of body weight daily, distributed across meals. High-protein intake also enhances satiety, complementing Mounjaro's appetite-suppressing effects and reducing the temptation to snack between meals.

Regular physical activity accelerates weight loss and improves metabolic health markers. Start with achievable goals such as 150 minutes of moderate-intensity exercise weekly — brisk walking, cycling, or swimming — and gradually increase duration and intensity as your fitness improves. Resistance training twice weekly helps maintain muscle mass and supports long-term weight maintenance.

Hydration and Alcohol Considerations

Adequate hydration is crucial, particularly if you experience diarrhoea or vomiting. Aim for at least 2 litres of water daily, increasing this if you're physically active or in warm weather. Dehydration can exacerbate side effects and impair kidney function, especially in patients taking other medications that affect fluid balance.

Limit alcohol consumption whilst taking Mounjaro, as alcohol can worsen gastrointestinal side effects and increase the risk of hypoglycaemia if you have diabetes. Alcohol also adds empty calories that may undermine your weight loss efforts. If you choose to drink, do so moderately and always with food.

How to Access Mounjaro Through Cured Pharmacy

Mounjaro is a prescription-only medication in the UK, requiring clinical assessment by a registered prescriber before dispensing. At Cured Pharmacy, the process begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any contraindications.

Our UK-registered clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), reviews every consultation within 24 hours. If Mounjaro is deemed suitable and safe for you, a prescription is issued and your medication is dispensed from our GPhC-registered pharmacy (9012511). All medicines are genuine UK-licensed products supplied in discreet packaging.

Mounjaro is available from £135.00 at Cured Pharmacy, with transparent pricing displayed before you begin your consultation. We guarantee the lowest prices in the UK for genuine licensed medications. Delivery is free and discreet, with next-day options available for most UK postcodes. Ongoing prescriptions require periodic review consultations to monitor your progress and adjust your dose as needed.

Comparing Mounjaro to Other Weight Loss Treatments

If Mounjaro is not suitable or you prefer an alternative, Cured Pharmacy offers a comprehensive range of MHRA-licensed weight loss treatments. Wegovy (semaglutide) is a once-weekly injectable GLP-1 agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [5]. Saxenda (liraglutide) requires daily injections and is an established option for patients who prefer more gradual dose adjustments.

Oral medications such as Orlistat and Xenical work by blocking fat absorption in the digestive system and are suitable for patients who prefer non-injectable treatments. Your UK prescriber will discuss all available options during your consultation and recommend the most appropriate treatment based on your clinical profile, preferences, and weight loss objectives.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on weight and cardiometabolic parameters in adults with obesity: SURMOUNT-1 extension study. The Lancet Diabetes & Endocrinology, 11(9), 632–643. https://doi.org/10.1016/S2213-8587(23)00189-X
3. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/14298
4. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication and must be prescribed following a consultation with a qualified healthcare professional. Always consult your GP or prescriber before starting any new medication, particularly if you have existing medical conditions or take other medications. Individual results may vary, and the clinical trial data referenced reflects average outcomes under controlled conditions. Never adjust your dose or stop treatment without consulting your prescriber.